JPRN-UMIN000028945
Not yet recruiting
Phase 2
Multicenter phase II trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the clinical course of anastomotic leakage after gastrectomy in patients with gastric cancer - Efficacy of Abound on the clinical course of anastomotic leakage after gastrectomy in patients with gastric cancer
agoya University0 sites20 target enrollmentNovember 1, 2017
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Anastomotic leakage after gastrectomy for gastric cancer
- Sponsor
- agoya University
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Severe pneumonia and sepsis 2\) Leakage at the closed stump of duodenum and jejunum 3\) Repeated surgery 4\) Patients requiring a limiting of the water amount 5\) Patients who underwent preoperative chemotherapy 6\) Patients incompatible to Abound 7\) Pregnancy 8\) Ineligible for the study at the physician's assessment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A clinical trial to evaluate the efficacy and safety ofpembrolizumab and gemcitabine in patients with HER2-negative Advanced Breast Cancer. PANGEA-Breast”Patients with HER2-negative advanced breast cancer.MedDRA version: 19.0Level: LLTClassification code 10072737Term: Advanced breast cancerSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-001779-54-ESGEICAM (Fundación Grupo Español de Investigación en Cáncer de Mama)36
Completed
Not Applicable
The efficacy of epirubicin, cisplatin and capecitabine in carcinomas of unknown primary origin (CUP): prospective validation of diagnosis, classfication and metabolic responsesCarcinoma of unknown primary origin (CUP)CancerISRCTN17282276HS Greater Glasgow and Clyde (UK)59
Completed
Phase 2
Multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancercolorectal cancerJPRN-UMIN000027887ational Cancer Center Hospital East30
Recruiting
Phase 2
A multicenter phase II study to evaluate the efficacy and safety of fixed-duration sequential treatment combined with novel agents and autologous stem cell transplantation for newly diagnosed elderly multiple myeloma. -JSCT EMM21JPRN-jRCTs071210084Kikushige Yoshikane75
Completed
Phase 2
A multicenter phase II trial of the efficacy and safety of tadalafil with pre-eclampsia.pregnancy induced hypertensionJPRN-UMIN000024042Mie university hospital, Department of Obstetrics and Gynecology160